Amneal Pharmaceuticals
AMRX
$5.87
Share price
-0.51%
Change (1 day)
222.53%
Change (1 year)
Categories
Operating Margin for Amneal Pharmaceuticals (AMRX)
Operating Margin as of April 2024 (TTM): -10.89%
According to Amneal Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -10.89%. At the end of 2021 the company had an Operating Margin of 8.01%.
Operating Margin history for Amneal Pharmaceuticals from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 8.01% | 44.79% |
| 2020 | 5.53% | -272.88% |
| 2019 | -3.20% | -10.05% |
| 2018 | -3.56% | -115.17% |
| 2017 | 23.45% | -11.6% |
| 2016 | 26.53% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | 233.88% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 76,953.72% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.